Related Experiment Videos
Phenotypic mapping of human mesothelial cells.
J A Ross1, I Ansell, J T Hjelle
1Molecular Immunology Group, University Department of Surgery, Royal Infirmary, Edinburgh, United Kingdom.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|January 29, 2000
Summary
This study identifies novel cell surface molecules on peritoneal mesothelial cells, crucial for understanding their role in health and disease, particularly during peritoneal dialysis.
Area of Science:
- Cell Biology
- Immunology
- Nephrology
Background:
- The mesothelium has a key homeostatic role in the peritoneum.
- Mesothelial cell function is significantly altered in disease and during peritoneal dialysis.
- The cell-surface phenotype of mesothelial cells remains incompletely understood.
Purpose of the Study:
- To identify cell surface molecules on mesothelial cells.
- To investigate molecules involved in mesothelial adhesion and immune cell interactions.
- To explore the significance of these molecules in peritoneal dialysis.
Main Methods:
- Flow cytometry and immunohistochemistry were used to analyze cell surface marker expression.
- A comprehensive panel of antibodies was employed to screen for known and novel markers.
- Expression levels of identified markers were quantified on human peritoneal mesothelial cells.
Main Results:
- Expression of adhesion molecules including CD44, CD29, CD61, and various integrin alpha chains (CD49a, CD49b, CD49c, CD49e, CD51) was characterized.
- Novel molecules such as CD90, CD105, CD140b, CD142, CD147, CD151, CD157, CD165, and CD166 were identified on mesothelial cells.
- The study provides a detailed profile of the mesothelial cell surface phenotype.
Conclusions:
- The identified cell surface molecules play roles in mesothelial cell adhesion and immune interactions.
- Understanding these molecules offers insights into mesothelial biology and pathology.
- This research has implications for improving peritoneal dialysis treatments and managing related complications.